000 04129naa a22006257i 4500
001 UMUN-OA-20261005-MLS-058
003 local
005 20261005174906.0
006 m o d
007 cr||||||||||||
008 261005s2017 xx o u000 0 eng d
024 7 _a10.4132/jptm.2017.03.14
_2doi
035 _a(local)EuropePMC:PMC5445206
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aJihun Kim
_eauthor.
245 1 0 _aGood Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests. /
_cJihun Kim; Woong-Yang Park; Nayoung K D Kim [and others].
264 1 _a[Place of publication not identified] :
_bKorean Society of Pathologists and Korean Society for Cytopathology,
_c2017.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aNext-generation sequencing (NGS) has recently emerged as an essential component of personalized cancer medicine due to its high throughput and low per-base cost. However, no sufficient guidelines for implementing NGS as a clinical molecular pathology test are established in Korea. To ensure clinical grade quality without inhibiting adoption of NGS, a taskforce team assembled by the Korean Society of Pathologists developed laboratory guidelines for NGS cancer panel testing procedures and requirements for clinical implementation of NGS. This consensus standard proposal consists of two parts: laboratory guidelines and requirements for clinical NGS laboratories. The laboratory guidelines part addressed several important issues across multistep NGS cancer panel tests including choice of gene panel and platform, sample handling, nucleic acid management, sample identity tracking, library preparation, sequencing, analysis and reporting. Requirements for clinical NGS tests were summarized in terms of documentation, validation, quality management, and other required written policies. Together with appropriate pathologist training and international laboratory standards, these laboratory standards would help molecular pathology laboratories to successfully implement NGS cancer panel tests in clinic. In this way, the oncology community would be able to help patients to benefit more from personalized cancer medicine.
540 _aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by-nc/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aNeoplasms
650 4 _aQuality control
650 4 _aMolecular Pathology
650 4 _aPractice Guidelines As Topic
650 4 _aHigh-throughput Nucleotide Sequencing
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _alaboratory quality
655 4 _aReview articles.
700 0 _aWoong-Yang Park
_eauthor.
700 0 _aNayoung K D Kim
_eauthor.
700 0 _aSe Jin Jang
_eauthor.
700 0 _aSung-Min Chun
_eauthor.
700 0 _aChang-Ohk Sung
_eauthor.
700 0 _aJene Choi
_eauthor.
700 0 _aYoung-Hyeh Ko
_eauthor.
700 0 _aYoon-La Choi
_eauthor.
700 0 _aHyo Sup Shim
_eauthor.
700 0 _aJae-Kyung Won
_eauthor.
700 0 _a
_eauthor.
773 0 _tJournal of pathology and translational medicine
_gVol. 51, no. 3, (2017), pages/article 191-204
_x2383-7837
856 4 0 _uhttps://europepmc.org/articles/PMC5445206
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC5445206
_qlocal
942 _n0
999 _c1200
_d1200